Colonic Diseases, Functional  >>  rezatomidine (AGN 203818)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rezatomidine (AGN 203818) / Acadia Pharma, AbbVie
NCT00441766: Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome Pain

Terminated
2
213
US
AGN 203818, placebo
Allergan
Irritable Bowel Syndrome
02/08
02/08

Download Options